5^th World Hematologists Congress August 18-19, 2016 London, UK

Dr. C.D. Atreya, Ph.D. is the Associate Director for research, Office of Blood Research and Review, Center for Biologics Research and Review at the U.S. Food and Drug Administration, USA. He has published more than 70 scientific publications in peer-reviewed journals and also serves on the editorial board for scientific journals of repute.

Hematology, Cellular Hematology

Michael Retsky (Ph.D in physics from University of Chicago) made a career change from physics to cancer research. He is Editor-in-Chief of Journal of Bioavailability and Bioequivalence, on staff at Harvard School of Public Health, honorary faculty at University College London, and Prof Adj at UANL, Monterrey, Mexico. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. He is on the board of directors of the Colon Cancer Alliance and has published more than 60 papers in physics and cancer. He has a patent pending for treatment of early stage cancer.

Cancer research, Hemato-Oncology

Ken Mills is the Chair of Experimental Hematology in the Centre for Cancer Research and Cell Biology (CCRCB) in Queen’s University Belfast. He coordinates the activities of the Blood Cancer Research Group with a focus on the molecular aspects of MDS and AML to identify novel therapies. He has published over 135 papers, several book chapters and he is on several Editorial Board and a regular Reviewer for high impact journals and national and international funding bodies.

Hematology, Blood Cancer Research, Molecular aspects of MDS

Dr John Batchelor is currently Consultant in Emergency Medicine at Central Manchester Foundation Trust, England UK. He is also Honorary Lecturer at Manchester Metropolitan University. He graduated from Leeds University England, in 1982.He is a Fellow of the Royal College of Surgeons of Ireland and Fellow of the Faculty of Emergency Medicine of England. He undertook his MD thesis at University College London. He has written extensively on the subject of minor head injuries.. He has presented a paper in Paris in 2012 on a Meta-analysis looking at the relationship between cerebral microbleeds and anitiplatelet agents. He has also recently published a meta-analysis on the effect on mortality of platelet transfusions in adults with spontaneous or traumatic antiplatelet associated intracranial haemorrhage. His current research interest lies in the area of risk factors for intracranial haemorrhage in both adults and paediatrics secondary to coagulopthy and thrombocytopenia.

Hematology, Transfusion Medicine,Thrombocytopenia

Currently, Dr. Bloomfield is a Distinguished University Professor at the Ohio State University (OSU). She is a holder of the William Greenville Pace III Endowed Chair in Cancer Research. She served as Director of the Division of Hematology and Oncology at OSU (1997–2001) and as Director of the OSU Comprehensive Cancer Center (1997-2003). She remains a Senior Advisor to the OSU Cancer Program and is a charter member of the OSU Cancer Scholars Program. Clara D. Bloomfield earned her MD at the University of Chicago and completed training in internal medicine and medical oncology at the University of Minnesota—where she became a full professor in 1980. She has been engaged in over 40 years of ground-breaking research in adult leukemia and lymphoma, resulting in over 1000 publications.

adult leukemia, lymphoma, Clinical Oncology

Enzi Jiang received her MD from Norman Bethune College of Medicine, Jilin University, formerly Norman Bethune University of Medical Science, Changchun, China in 1987. She completed her PhD from Harbin Medical University in 1999 and Postdoctoral research from University of Texas Southwestern Medical Center at Dallas in 2007. She is working as a Senior Scientist at Division of Hematology and Oncology, Children’s Hospital Los Angeles University of Southern California Keck School of Medicine, Los Angeles, USA. She has published more than 15 papers in reputed journals related to mesenchymal stem cells and leukemia and contributed to a book chapter (Chapter 4: Molecular Pathogenesis of ALL, Contemporary Management of Acute Lymphoblastic Leukemia, In Press 2014). She has been serving as an Editorial Board Member for the Journal of Blood Disorders and Transfusion since February, 2013. Her research interests include overcoming drug resistance in ALL and related mechanisms.

Hematology and Oncology

C Cameron Yin has received her MD from Beijing Medical University and her PhD from the University of Wisconsin-Madison. She is currently an Associate Professor in the Department of Hematopathology at the University of Texas MD Anderson Cancer Center. In addition to clinical responsibilities on the Leukemia, Lymphoma and Molecular Diagnostic services, she has been actively participating in multiple research projects in the molecular genetic abnormalities in leukemia and lymphoma which has led to over 100 research papers and over 20 book chapters.

Leukemia, Lymphoma, Molecular Diagnostic, Molecular genetic abnormalities in leukemia and lymphoma